This site is intended for qualified researchers aged 21 or older.
Tirzepatide is a synthetic peptide acting as a dual agonist at the GLP-1 and GIP receptors. It is the active compound in FDA-approved therapeutics marketed under separate brand names and has been extensively examined in research for metabolic signaling, appetite mechanisms, and glycemic regulation. Each vial is lyophilized, sealed, and shipped with a lot-specific Certificate of Analysis.